Investigating the Effect of Estradiol Levels on the Risk of Breast, Endometrial, and Ovarian Cancer.

Johansson, Åsa; Schmitz, Daniel; Höglund, Julia; Hadizadeh, Fatemeh; Karlsson, Torgny; Ek, Weronica E

Johansson, Åsa; Schmitz, Daniel; Höglund, Julia; Hadizadeh, Fatemeh; Karlsson, Torgny; Ek, Weronica E.

Afiliación

Johansson Å; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75108 Uppsala, Sweden.
Schmitz D; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75108 Uppsala, Sweden.
Höglund J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75108 Uppsala, Sweden.
Hadizadeh F; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75108 Uppsala, Sweden.
Karlsson T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75108 Uppsala, Sweden.
Ek WE; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75108 Uppsala, Sweden.

J Endocr Soc ; 6(8): bvac100, 2022 Aug 01.

Article en En | MEDLINE | ID: mdl-35822202

Palabras clave

Mendelian randomization; breast cancer; endometrial cancer; estradiol; ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Endocr Soc Año: 2022 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google